Results 31 to 40 of about 270,199 (315)

Impact of psychiatric pharmacist-led ambulatory alcohol withdrawal management [PDF]

Mental Health Clinician
Introduction Alcohol withdrawal syndrome (AWS) is a complication of alcohol use disorder commonly encountered across various healthcare settings. Management of AWS is routinely conducted in the inpatient setting; however, in numerous patients, ambulatory
Maxwell Lamb, PharmD, BCPS, Michelle Colvard, PharmD, BCPP, Jonathan Lister, PharmD, BCPP, Eric Johnson, PharmD, BCPP   +3 more
doaj   +1 more source

Predictors of substance use among Jimma University instructors, Southwest Ethiopia

Substance Abuse Treatment, Prevention, and Policy, 2020
Background Use of substances such as alcohol, khat leaves (Catha edulis) and tobacco has become one of the rising major public health and socioeconomic problems worldwide and dramatically increased in developing countries.
Abraham Tamirat Gizaw, Demuma Amdisa, Yohannes Kebede Lemu   +2 more
doaj   +1 more source

Impact of continuing care on recovery from substance use disorder.

, 2021
Continuing care is widely believed to be an important component of effective treatment for substance use disorder, particularly for those individuals with greater problem severity.
McKay, James R
core   +1 more source

Substance Use Disorder Comorbidity in Schizophrenia [PDF]

Psikiyatride Güncel Yaklaşımlar, 2013
Use of alcohol and other substances are commonly observed among patients with a diagnosis of schizophrenia. Despite this common comorbidity, there have been very few studies which do not take alcohol/substance use as an exclusion criterion.
Hatice İmer Aras
doaj   +1 more source

Quality of life and substance use in Lebanese medical students [PDF]

, 2023
Background: Substance use is prevalent among medical students and could affect their academic performance. This study aimed to determine whether a relationship exists between quality of life and substance use among medical students in Lebanon.
Serhan, Fatima G., Mariana Helou, Souheil Hallit, Helou, Mariana, Akl, Michel, Soufia, Michel, Mouawad, Yara, Georges-Alain Al Tekle, Hallit, Souheil R., Michel Akl, Michel Soufia, Fatima Serhan, Al Tekle, Georges Alain, Yara Mouawad   +13 more
core   +1 more source

The perspectives of people who use drugs regarding short term involuntary substance use care for severe substance use disorders

, 2021
Background: In the Canadian Province of British Columbia (BC), the BC Mental Health Act permits involuntary care for treating mental disorders. However, the Act has also been applied to provide involuntary care to individuals with a primary substance ...
Winston, Mark L., Pakhomova, Tatiana E., Thompson, Erica, MacPherson, Donald, Small, Will, Lou, Hayami, Vigo, Daniel V., Chau, Leena W., Erickson, Margaret   +8 more
core   +1 more source

Lessons from the National institutes of health innovation corps program: defining barriers to developing and commercializing novel solutions for persons with opioid use disorder

Addiction Science & Clinical Practice
Background Translating innovative research advancements into commercially viable medical interventions presents well-known challenges. However, there is limited understanding of how specific patient, clinical, social, and legal complexities have further ...
Matthew P. Heshmatipour, Tyler M. Duvernay, Desislava Z. Hite, Eboo Versi, Michael P. Hite, David F. Reeser, Victor Prikhodko, Ariana M. Nelson, Bina Julian, Milton L. Greenberg   +9 more
doaj   +1 more source

Kratom Use in the US: Both a Regional Phenomenon and a White Middle-Class Phenomenon? Evidence From NSDUH 2019 and an Online Convenience Sample

Frontiers in Pharmacology, 2021
Kratom products available in the United States are becoming increasingly diverse both in terms of content and in terms of how they are marketed.
Jeffrey M. Rogers, Kirsten E. Smith, Justin C. Strickland, David H. Epstein   +3 more
doaj   +1 more source

Clinical and Biological Features of Response in Resistant Neuroblastoma to 131I‐Metaiodobenzylguanidine Radiotherapy in the Anti‐GD2 Immunotherapy Era

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background 131I‐metaiodobenzylguanidine (131I‐MIBG) radiotherapy is a key treatment for relapsed and refractory (R/R) neuroblastoma (NB). Patients with R/R disease treated in the modern era are increasingly exposed to anti‐GD2 immunotherapy, which exerts selective pressure and may modify both tumor cell state and microenvironment.
Benjamin J. Lerman, Katherine K. Matthay, Fabienne Hollinger, Catriona Black, Ann A. Lazar, Miguel Pampaloni, Steven G. DuBois, Kieuhoa T. Vo   +7 more
wiley   +1 more source

Medications for Substance Use Disorders [PDF]

Social Work in Public Health, 2013
In this article, the authors briefly review the pharmacotherapeutic agents that are currently available for the treatment of substance use disorders. Nicotine replacement therapies are most effective for tobacco cessation. Naltrexone, acamprosate, and disulfiram are effective for reducing alcohol use. The most effective pharmacotherapies for opiate use
Antoine B, Douaihy, Thomas M, Kelly, Carl, Sullivan   +2 more
openaire   +2 more sources